BackArcutis Biotherapeutics Overview

Arcutis Biotherapeutics Intangible Assets

Track Arcutis Biotherapeutics's intangible assets ($14M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$13.69M
14.12% YoYΔ $-2.25M vs prior year quarter

Peer trimmed avg / median

Loading

Arcutis Biotherapeutics Intangible Assets History

Loading

Arcutis Biotherapeutics vs. peers: Intangible Assets Comparison

Loading

Arcutis Biotherapeutics Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Arcutis Biotherapeutics (ARQT) FAQ

Arcutis Biotherapeutics (ARQT) currently reports a intangible assets of $14M as of June 2026. That compares with $16M in the prior-year period — down 14.1% year over year. Use the charts on this page to explore Arcutis Biotherapeutics's intangible assets history and peer comparisons.

Arcutis Biotherapeutics's intangible assets decreased from $16M to $14M — a 14.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Arcutis Biotherapeutics reported $14M in intangible assets as of June 2026. That compares with $16M in the prior-year period — down 14.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Arcutis Biotherapeutics, and consider following ARQT for alerts when major investors trade the stock.

Arcutis Biotherapeutics is classified in the Healthcare sector. On intangible assets, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ARQT with unrelated industries.